Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | RSS
On this episode of Stay in the Game, Joe Cosgriff welcomes Dr. Cordell Nwokeji of Houston Premier Urology—Texas’s first physician accredited to perform HIFU, pioneering the procedure there in 2016—and patient advocate Jack Sells, CEO/President of Sales Search America, for a thoughtful conversation about focal therapy as an increasingly accepted treatment option for prostate cancer. Sells explains how his career in the medical device industry gave him unusual insight into the treatment landscape and helped him make a well-informed treatment decision. Dr. Nwokeji’s guiding principle is minimizing the “collateral damage” that can accompany treatment, while Sells focused on minimizing the risk of recurrence. Though they approached the decision from different perspectives, both concluded that HIFU with the Sonablate system offered the right balance of effective cancer control and quality of life.
Program Notes
About Sonablate
About Dr. Cordell Nwokeji
Dr. Cordell Nwokeji is a urologist at Houston Premier Urology who specializes in minimally invasive therapies for prostate cancer, with a particular focus on focal therapy. A pioneer in the field, he became the first physician in Texas accredited to perform HIFU in 2016 and has helped many men preserve their quality of life while effectively treating their disease.
About Jack Sells
Jack Sells is CEO/President of Sales Search America and a nationally recognized prostate cancer patient advocate. Drawing on decades of experience in the medical device industry, he shares a unique perspective on evaluating treatment options and is committed to helping men make informed decisions about their own prostate cancer journeys.
